Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CPLB | 20.23 | 0.04 | +0.20% |
| NYLIM MacKay Core Plus Bond ETF (CPLB) | |||
| HSMV | 35.74 | N/A | N/A |
| First Trust Horizon Managed Volatility Small/Mid ETF (HSMV) | |||
| EWU | 44.74 | -0.72 | -1.58% |
| iShares MSCI United Kingdom ETF (EWU) | |||
| PBDE | 29.89 | -0.71 | -2.32% |
| PGIM S&P 500 Buffer 20 ETF - December (PBDE) | |||
| ORCX | 9.09 | -1.85 | -16.91% |
| Defiance Daily Target 2X Long ORCL ETF (ORCX) | |||
| Ticker / NAME | Correlation To FRNM | 1D Price Change % |
|---|---|---|
| FRNM | 100% | -5.69% |
| Medical Specialties category (43 stocks) | 11% Poorly correlated | -3.22% |
| Medical Specialties category (43 stocks) | 11% Poorly correlated | -3.22% |
Industry MedicalSpecialties